Dr. Alla M. Solyar, MD

Dr. Solyar practices at Sinus & Nasal Institute of Florida PA in Saint Petersburg, Florida.

Dr. Solyar's NPI, 1265762108, was assigned on December 27, 2009. Dr. Solyar graduated from Albert Einstein College of Medicine in 2005. Dr. Solyar holds Florida license ME107053.

Dr. Solyar's primary practice is Sinus & Nasal Institute of Florida PA, at 550 94th N Ave, Saint Petersburg, FL 33702 in Pinellas County. The practice phone is (727) 573-0074.

Dr. Solyar's primary practice is Sinus & Nasal Institute of Florida PA in Saint Petersburg, Florida. Dr. Solyar is also affiliated with BayCare St. Anthony's Hospital. The medical group on file is Sinus & Nasal Institute of Florida. Dmand AI also links Dr. Solyar to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Solyar practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Solyar's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Solyar is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Solyar's licenses on file in 2 states: Florida and New Jersey.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis and endoscopic sinus surgery among the conditions Dr. Solyar treats.

CMS data shows 1,112 Medicare services from Dr. Solyar across 10 procedure codes in 2024, for 244 Medicare patients. Medicare paid $135,573 for them.

CMS counts 244 Medicare patients who saw Dr. Solyar in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Solyar's median patient age at 66, with 53% women.

In 2024, Dr. Solyar wrote 784 Medicare Part D claims for 198 patients. 79% of them were for generic drugs. CMS names the drug for 690 of them, across 19 drugs with 11 or more claims each, at $81,788 in total drug cost. In 2023, CMS named 674 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Solyar for performance year 2024, reported as part of a group. Dr. Solyar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Solyar as offering telehealth.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Solyar, published from 2008 to 2021. The most frequent topics are Endoscopy, Encephalocele and Geniculate Ganglion. Dr. Solyar has published most often in Int Forum Allergy Rhinol. Dr. Solyar's most frequent co-authors are Donald C. Lanza, MD, Sean Paul Chislett, MD and Alexander Philip Limjuco, MD.

CMS Open Payments shows 40 general payments to Dr. Solyar from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 33% of the total. Optinose US, Inc. paid the most, $12,222.

Dmand AI lists 1 award for Dr. Solyar, most recently CMS Stage 1 EHR in 2013. Dr. Solyar serves on American Rhinologic Society Patient Advocacy Committee and St. Anthony’s Hospital CME Committee.

Dr. Solyar graduated from Albert Einstein College of Medicine in 2005. Dr. Solyar is a member of American Academy of Otolaryngic Allergy, NHS, American Rhinologic Society and Florida Medical Association.

Dr. Solyar is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.